Vaccine HPV
Cervical cancer is the second most common cancer in women aged 20-44, after breast cancer.1* Unlike most cancers, it's caused by a virus called HPV that's common in teens and young adults.1,2 By deciding to get the Cervarix™ vaccine now, you can help protect yourself against the HPV types that cause most cases of cervical cancer (HPV 16 and 18).1
Vaccination reminder
Sign up for helpful vaccination reminders.
Cervarix™ helps protect females aged 10-25 years against cervical cancer and abnormal and precancerous cervical lesions caused by HPV 16 and 18. It does not treat these conditions and does not protect against all HPV types. Duration of protection has not been established. 100% protection cannot be guaranteed and continued routine screening is necessary. Side effects and allergic reaction may occur. Ask your doctor if Cervarix™ is right for you.
*Cervarix™ is for females aged 10-25.
Cervarix™ is used under license by GlaxoSmithKline Inc. ©2010 GlaxoSmithKline Inc. All rights reserved.
This site is not intended as a means for reporting an adverse event for any GSK product. To report an adverse event, please call 1-800-387-7374. The contents of this site are for information purposes only and are not, in any way, intended to replace or substitute the advice of your physician. This site does not provide medical advice. Please read legal information.